Product NDC: | 52584-633 |
Proprietary Name: | Verapamil Hydrochloride |
Non Proprietary Name: | Verapamil Hydrochloride |
Active Ingredient(s): | 2.5 mg/mL & nbsp; Verapamil Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-633 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075136 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100301 |
Package NDC: | 52584-633-05 |
Package Description: | 1 BOX in 1 BAG (52584-633-05) > 1 SYRINGE in 1 BOX > 4 mL in 1 SYRINGE |
NDC Code | 52584-633-05 |
Proprietary Name | Verapamil Hydrochloride |
Package Description | 1 BOX in 1 BAG (52584-633-05) > 1 SYRINGE in 1 BOX > 4 mL in 1 SYRINGE |
Product NDC | 52584-633 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Verapamil Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100301 |
Marketing Category Name | ANDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Strength Number | 2.5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |